SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
OpGen, Inc. (OPGN) trades at a trailing P/E of 10.4. Trailing earnings yield is 9.62%.
Criteria proven by this page:
- VALUE (50/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Trailing Earnings Yield 9.62% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $0.67 (-97.2% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 65/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
50/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — OPGN
Valuation Multiples
P/E (TTM)10.4
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio24.02
EV/EBITDA0.0
Per Share Data
EPS (TTM)$2.30
Book Value / Share$0.00
Revenue / Share$1.00
FCF / Share$0.00
Yields & Fair Value
Earnings Yield9.62%
Dividend Yield0.00%
Analyst Target$0.67 (-97.2%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-140,767.00 |
$3.16M |
$-17.35M |
-549.5% |
| 2016 |
$-10,853.20 |
$4.03M |
$-19.17M |
-476.1% |
| 2017 |
$-27,195.80 |
$3.21M |
$-15.42M |
-480.2% |
| 2018 |
$-8,880.00 |
$2.95M |
$-13.37M |
-453.8% |
| 2019 |
$-1,540.00 |
$3.5M |
$-12.45M |
-355.7% |
| 2020 |
$-331.77 |
$4.21M |
$-26.21M |
-622% |
| 2021 |
$-228.00 |
$4.31M |
$-34.81M |
-808.3% |
| 2022 |
$-152.70 |
$2.61M |
$-37.28M |
-1430.1% |
| 2023 |
$-41.47 |
$3.42M |
$-32.67M |
-955.8% |
| 2024 |
$2.30 |
$5.2M |
$11.99M |
230.8% |
